HTLV‐1 is the etiologic agent of ATL and HAM/TSP. The majority of HTLV‐1‐infected
individuals remain asymptomatic, indicating that the infection alone is not sufficient to cause …

The human T-lymphotropic virus 1 (HTLV-1) is the causative agent of HTLV-1-associated
myelopathy/tropical spastic paraparesis (HAM/TSP). The present study investigated the …

Abstract Background HTLV-1-associated myelopathy/tropical spastic paraparesis
(HAM/TSP) is a progressive neurological and inflammatory disease, associated with HTLV-1 …

To investigate non-human leukocyte antigen candidate genes that influence the outcome of
human T cell lymphotropic virus (HTLV) type I infection, we analyzed 6 single-nucleotide …

The underlying mechanisms leading to the development of human T-cell lymphotropic virus
type I (HTLV-I) associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I …

Interleukin‐18 (IL‐18) and interferon‐gamma (IFN‐γ) exert important functions in both innate
and adaptive immune responses against intracellular pathogens and viruses. Previous …

Background/Aims: Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that
causes a persistent infection, and only 0.5-5% of infected individuals will develop HTLV-1 …

Human T‐lymphotropic virus type 1 (HTLV‐1) is the agent of the HTLV‐1‐associated
myelopathy/tropical spastic paraparesis (HAM/TSP), which may occur in> 5% of patients …

Most human T-lymphotropic virus type 1 (HTLV-1)-infected patients remain asymptomatic
throughout life. The factors associated with HTLV-1-associated myelopathy/tropical spastic …

Although human T-lymphotropic virus type I (HTLV-I) exhibits high genetic stability, as
compared to other RNA viruses and particularly to human immunodeficiency virus (HIV) …